We identify that CN-0928 binding to the target protein INTS1 allows control of PCBP2 expression, possibly through a transcriptional mechanism, and the reduced PCBP2 protein level and condensation are then responsible for the alleviated AD pathologies. This evidence concerns the gene INTS1 and Alzheimer disease.